| |
Total (n = 120)
|
Women (n = 86)
|
Men (n = 34)
|
|---|
|
Gender, n (%)
| | | |
|
Female
|
86 (72)
| | |
|
Male
|
34 (28)
| | |
|
Age, mean, (SD),
| | | |
|
Years
|
72 (7.7)
|
72 (7.8)
|
74 (7.6)
|
|
Disease classification, n (%)
| | | |
|
GOLD group A
|
21 (18)
|
18 (21)
|
3 (9)
|
|
GOLD group B
|
50 (42)
|
32 (37)
|
18 (53)
|
|
GOLD group C
|
5 (4)
|
1 (1)
|
4 (12)
|
|
GOLD group D
|
44 (37)
|
35 (41)
|
9 (26)
|
|
Civil status, n (%)
| | | |
|
Living alone
|
61 (51)
|
51 (59)
|
10 (29)
|
|
Living together
|
59 (49)
|
35 (41)
|
24 (71)
|
|
Living condition, n (%)
| | | |
|
Villa or house
|
34 (28)
|
22 (26)
|
12 (35)
|
|
Apartment
|
86 (72)
|
64 (74)
|
22 (65)
|
|
Domestic home care, n (%)
|
13 (11)
|
10 (12)
|
3 (9)
|
|
Occupation, n (%)
| | | |
|
Working
|
16 (13)
|
10 (12)
|
6 (18)
|
|
Not working
|
104 (87)
|
76 (88)
|
28 (82)
|
|
Education status, n (%)
| | | |
|
≤ 8 years
|
19 (16)
|
12 (14)
|
7 (21)
|
|
9 years
|
17 (14)
|
14 (16)
|
3 (9)
|
|
10–11 years
|
17 (14)
|
14 (16)
|
3 (9)
|
|
≥ 12 years
|
67 (56)
|
46 (54)
|
21 (62)
|
|
Oxygen treatmenta, n (%)
|
10 (8)
|
7 (8)
|
3 (9)
|
|
α-1-antiprypsin deficiency, n (%)
|
3 (2)
|
2 (2)
|
1 (3)
|
|
Smoking status, n (%)
| | | |
|
Current smoker
|
16 (13)
|
11 (13)
|
5 (15)
|
|
Former smoker
|
100 (83)
|
73 (85)
|
27 (79)
|
|
Never smoker
|
4 (3)
|
2 (2)
|
2 (6)
|
|
BMI, mean (SD)
|
27 (5.5)*
|
27 (5.6)*
|
26 (5.0)
|
|
CAT total score, median
|
15
|
15.5
|
14.5
|
|
(min–max)
|
(1–36)
|
(2–36)
|
(1–31)
|
|
Frändin-Grimby activity scaleb, median
|
4
|
4
|
3
|
|
(min–max)
|
(1–6)
|
(1–5)
|
(1–6)
|
|
Walking aidc, n (%)
|
39 (32)
|
33 (38)
|
6 (18)
|
|
Comorbidities, n (%)
| | | |
|
Hypertension
|
70 (58)
|
50 (58)
|
20 (59)
|
|
Heart diseased
|
38 (32)
|
26 (30)
|
12 (35)
|
|
Anxiety, depression
|
33 (28)
|
31 (36)
|
2 (6)
|
|
Osteoporosis
|
33 (28)*
|
30 (35)*
|
3 (9)
|
|
Cancer
|
26 (22)**
|
20 (24)*
|
6 (18)*
|
|
Diabetes
|
17 (14)
|
9 (11)
|
8 (24)
|
|
Sleep apnea syndrome
|
15 (12)
|
11 (13)
|
4 (12)
|
|
Stroke
|
8 (7)
|
5 (6)
|
3 (9)
|
- BMI, Body mass index; CAT, COPD Assessment Test; COPD, Chronic obstructive pulmonary disease; GOLD group, Global Initiative for Chronic Obstructive Lung Disease group; HRQL, health related quality of life
- aOxygen treatment ≥ 16 h/d and/or at activity, bA six-degree activity scale, including household activities, ranging from 1- “hardly any physical activity”, 2- “mostly sedentary”, 3- “easier physical exercise 2–4 h per week”, 4- “more strenuous exercise 1–2 h per week” 5- “more strenuous exercise > 3 h per week” to 6- “hard exercise several times a week”. cWalking aid used outdoor walker, cane or other. dHeart disease: myocardial infraction, heart failure, angina pectoris
- *One missing value, ** two missing values
